Back to results
US 2013/0210825 A1Published application
Substituted imidazo[1,2-b]pyridazines
AssigneeBayer Intellectual Property GmbH
InventorsHartmut Rehwinkel, Andrea Hägebarth, Oliver Politz, Roland Neuhaus, Ulf Bömer
Life of this patent
Estimating the term…
Abstract
The invention relates to imidazo[1,2-b]pyridazines of general formula (I) a process for their manufacuture and their use for the treatment of benign and malignant neoplasia.
Claims18
A compound of formula (I)
- wherein
- R1 is hydrogen, halogen, 2-6C-alkenylen-C(O)NH2, 2-6C-alkenylen-C(O)OR10, or a group selected from 1-6C-alkyl, 2-6C-alkenyl, 3-7C-cycloalkyl, aryl, heteroaryl, wherein said group being optionally substituted, one or more times, identically or differently, with a substituent selected from:
- hydroxy, halogen, 1-6C-alkyl, 1-4C-haloalkyl, 1-4C-hydroxyalkyl, 1-6C-alkoxy, —NR8R9, cyano, —C(O)NR8R9, —C(O)OR10, —NHC(O)R11, —NHS(O)2R11, —S(O)2R11, —S(O)2NR8R9,
- R2 is hydrogen, halogen, cyano, or a group selected from 1-6C-alkyl, 3-7C-cycloalkyl,
- wherein said 1-6C-alkyl being optionally substituted, one or more times, identically or differently, with a substituent selected from:
- hydroxy, halogen, 1-6C-alkoxy,
- R3 is hydrogen, 1-6C-alkyl, 3-7C-cycloalkyl,
- R4 is phenyl optionally substituted, one or more times, identically or differently, with a substituent selected from:
- 1-6C-alkyl, halogen, cyano,
- R5 is hydrogen, halogen,
- R6 is hydrogen, 1-6C-alkyl,
- R8, R9 which can be the same or different, is hydrogen, 1-4C-alkyl or 3-7C-cycloalkyl, wherein said 1-4C-alkyl and 3-7C-cycloalkyl is optionally substituted in the same way of differently one or more times with halogen, hydroxy, mono- or di-1-4C-alkylamino, 1-4C-alkoxy,
- or,
- in the case of —NR8R9, R8 and R9 together with the nitrogen to which they are attached may also form a 3-6C-heterocyclic ring,
- R10 is hydrogen, 1-6C-alkyl,
- R11 is 1-4C-alkyl (optionally substituted in the same way of differently one or more times with halogen, hydroxy) or 3-7C-cycloalkyl,
- X is —(CH2)n—,
- n is 0, 1, 2, or 3,
- Y is —CH2—, —CH(OH)—,
- or an N-oxide, a salt, a tautomer or a stereoisomer of said compound, or a salt of said N-oxide, tautomer or stereoisomer.
17 more elements
A compound of formula (II),
- wherein
- Rx is R6 or a protecting group,
- Ry is hydrogen or a protecting group,
- whereby Rx and Ry together, or Y and Rx together, may form a cyclic protecting group,
- R1 is hydrogen, halogen, 2-6C-alkenylen-C(O)NH2, 2-6C-alkenylen-C(O)OR10, or a group selected from 1-6C-alkyl, 2-6C-alkenyl, 3-7C-cycloalkyl, aryl, heteroaryl, wherein said group being optionally substituted, one or more times, identically or differently, with a substituent selected from:
- hydroxy, halogen, 1-6C-alkyl, 1-4C-haloalkyl, 1-4C-hydroxyalkyl, 1-6C-alkoxy, —NR8R9, cyano, —C(O)NR8R9, —C(O)OR10, —NHC(O)R11, —NHS(O)2R11, —S(O)2R11, —S(O)2NR8R9,
- R2 is hydrogen, halogen, cyano, or a group selected from 1-6C-alkyl, 3-7C-cycloalkyl,
- wherein said 1-6C-alkyl being optionally substituted, one or more times, identically or differently, with a substituent selected from:
- hydroxy, halogen, 1-6C-alkoxy,
- R3 is hydrogen, 1-6C-alkyl, 3-7C-cycloalkyl,
- R4 is phenyl optionally substituted, one or more times, identically or differently, with a substituent selected from:
- 1-6C-alkyl, halogen, cyano,
- R5 is hydrogen, halogen,
- R6 is hydrogen, 1-6C-alkyl,
- R8, R9 which can be the same or different, is hydrogen, 1-4C-alkyl or 3-7C-cycloalkyl, wherein said 1-4C-alkyl and 3-7C-cycloalkyl is optionally substituted in the same way of differently one or more times with halogen, hydroxy, mono- or di-1-4C-alkylamino, 1-4C-alkoxy,
- or,
- in the case of —NR8R9, R8 and R9 together with the nitrogen to which they are attached may also form a 3-6C-heterocyclic ring,
- R10 is hydrogen, 1-6C-alkyl,
- R11 is 1-4C-alkyl (optionally substituted in the same way of differently one or more times with halogen, hydroxy) or 3-7C-cycloalkyl,
- X is (CH2)n—,
- n is 0, 1, 2, or 3, and
- Y is —CH2—, —CH(OH)—.
19 more elements
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.